Cytomegaloviral retinitis 1 g tid as maintenance dose.
Prophylaxis of cytomegaloviral infections in immunocompromised patients 1 g tid.
Cytomegaloviral infections. Initial: 5 mg/kg 12 hrly for 14-21 days, then 5 mg/kg once daily for 7 days/wk or 6 mg/kg once daily for 5 days/wk.
Prophylaxis of cytomegaloviral infections in immunocompromised patients. Initial: 5 mg/kg 12 hrly for 7-14 days, then 5 mg/kg once daily for 7 days/wk or 6 mg/kg once daily for 5 days/wk.
Herpes simplex keratitis - 0.15% gel: Apply 1 drop in the inferior conjunctival sac of the affected eye 5 times/day.
Adverse drug reactions
: hematologic effects (e.g., neutropenia, thrombocytopenia, anaemia, eosinophilia), headache, seizure, coma, confusion, thought disorders, dysphoria, agitation, hallucinations, abnormal dreams/nightmares, nervousness/anxiety, delirium, dizziness, dysesthesia, asthenia, intention tremor, abnormal reflexes, ataxia, paresthesia, psychosis, somnolence, obtundation, elevated serum aminotransferase and alkaline phosphatase levels, nausea, vomiting, diarrhea, anorexia, GI hemorrhage, increased serum creatinine and BUN levels.
Adapted from CIMS Drug Information System. Internet. Accessed on January 10, 2016.